FOLINIC ACID, CETUXIMAB, IRINOTECAN, FLUOROURACIL clinical trials

Randomized study to compare first-line treatment with either continuous or intermittent cetuximab plus FOLFIRI in patients with RAS/BRAF-wild-type metastatic colorectal cancer (mCRC): AIO-KRK-0524 / FIRE-11

This study looks at different ways to give cetuximab with other drugs (FOLFIRI) for advanced bowel cancer that has spread. It wants to see if giving cetuximab continuously or in breaks affects how well the treatment works and patients' quality of life.